From October 1, 2023 to February 8, 2024, the company has repurchased 194,554 shares, representing 0.12% for CNY 20.06 million. With this, the company has completed the repurchase of 496,600 shares, representing 0.32% for CNY 49.98 million under the buyback announced on August 11, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
107.5 CNY | +0.49% | -1.19% | -14.60% |
Apr. 22 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
Apr. 22 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.60% | 2.34B | |
+2.35% | 29.77B | |
+4.50% | 21.6B | |
+13.39% | 11.83B | |
+12.40% | 5.15B | |
+11.10% | 4.21B | |
-16.49% | 3.48B | |
-3.79% | 3.14B | |
+4.73% | 3.11B | |
+27.19% | 2.79B |
- Stock Market
- Equities
- 688639 Stock
- News Anhui Huaheng Biotechnology Co., Ltd.
- Tranche Update on Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback Plan announced on August 11, 2023.